[Should chronic active viral hepatitis be treated with drugs or not?].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002353:Carrier State / Q000188:drug therapy; D006509:Hepatitis B / Q000188:drug therapy* / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008111:Liver Function Tests; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens; D007166:Immunosuppressive Agents; D011239:Prednisolone; D001379:Azathioprine; D011241:Prednisone
Soll die chronisch-aktive Virus-Hepatitis medikamentös behandelt werden oder nicht?